A growing segment of the U.S. physician population are subject to restrictions on meeting in-person with pharma sales reps in their primary practice. However, this rep-restricted physician cohort continues to look to pharma for a variety of product- and patient-related information and services. This Strategic Insight explores where opportunities exist for marketers to connect with restricted physicians, and how pharma companies can continue to provide value to physicians in an increasingly restricted environment.
Question answered in this report:
How many physicians work in practices or hospitals with restrictions on seeing reps? To what extent do these physicians engage with digital resources from pharma companies? How can pharma marketers ensure they provide rep-restricted physicians with the info and services they look for from pharma?